|
2025
|
Invention
|
Oxytocin peptide analogs. The present disclosure relates to oxytocin peptide analogs, or an enant... |
|
|
Invention
|
Cyclobenzaprine treatment for acute stress reaction or acute stress disorder. The present disclos... |
|
2024
|
Invention
|
Early onset response, favorable tolerability, and side effect profile in the treatment of fibromy... |
|
|
Invention
|
Cyclobenzaprine hcl for use in treating fibromyalgia with early onset response and favorable tole... |
|
|
Invention
|
Analogs of cyclobenzaprine and amitryptilene.
The present invention relates to cyclobenzaprine a... |
|
|
Invention
|
(s)-tianeptine and use in treating disorders and conditions associated with peroxisome proliferat... |
|
2023
|
Invention
|
Cyclobenzaprine treatment for post-acute sequelae of (sars)-cov-2 infection (pasc). The present d... |
|
|
Invention
|
Recombinant poxvirus based vaccine against the omicron strain of sars-cov-2 virus and variants th... |
|
2022
|
Invention
|
Analogs of cyclobenzaprine and amitryptilene. The present invention relates to cyclobenzaprine an... |
|
|
Invention
|
Radio-protective and chemo-protective substituted thiols.
The present disclosure relates to prod... |
|
|
Invention
|
Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health c... |
|
|
Invention
|
Tianeptine oxalate and naloxone combination for the treatment of major depressive disorder.
A co... |
|
|
Invention
|
Tianeptine oxalate and naloxone combination for the treatment of major depressive disorder. A com... |
|
|
Invention
|
An improved method of assessing clinical response in the treatment of ptsd symptoms. |
|
2021
|
Invention
|
Cyclobenzaprine treatment for fibromyalgia. Methods for treating fibromyalgia and one or more of ... |
|
|
Invention
|
Cyclobenzaprine treatment for alcohol use disorder. The present disclosure provides a method for ... |
|
|
Invention
|
Randomization honoring methods to assess the significance of interventions on outcomes in disorde... |
|
|
Invention
|
Skin-based testing for detection of cell-mediated immune responses to sars-cov-2. The present dis... |
|
|
Invention
|
Skin-based testing for detection of cell-mediated immune responses to sars-cov-2.
The present di... |
|
|
Invention
|
Radio-and chemo-protective compounds.
The present disclosure relates to prodrugs, double prodrug... |
|
|
Invention
|
Radio-protective and chemo-protective substituted thiols. The present disclosure relates to prodr... |
|
|
Invention
|
Radio-and chemo-protective compounds. The present disclosure relates to prodrugs, double prodrugs... |
|
|
Invention
|
Cyclobenzaprine treatment for sexual dysfunction. The present disclosure provides a pharmaceutica... |
|
|
Invention
|
Recombinant poxvirus based vaccine against sars-cov-2 virus. The invention relates in various asp... |
|
|
Invention
|
Recombinant poxvirus based vaccine against sars-cov-2 virus.
The invention relates in various as... |
|
2020
|
Invention
|
Inhibitors of cd40-cd154 binding.
Disclosed herein are compounds including pharmaceutically acce... |
|
|
Invention
|
Inhibitors of cd40-cd154 binding. Disclosed herein are compounds including pharmaceutically accep... |
|
2018
|
Invention
|
Analogs of cyclobenzaprine and amitriptyline. The present invention relates to cyclobenzaprine an... |
|
2017
|
Invention
|
Salts and polymorphs of esreboxetine.
Disclosed herein are salts and polylmoprhs of (2S)-2-[(S)-... |
|
|
Invention
|
Salts and polymorphs of esreboxetine. Disclosed herein are salts and polylmoprhs of (2S)-2-[(S)-(... |
|
2011
|
Invention
|
Treatment for cocaine addiction.
A novel pharmaceutical composition is provided for the control ... |
